Chemours has reported its financial results for the second quarter of 2026. Net sales totalled USD 1,591 million, approximately flat compared with USD 1,615 million in the prior-year quarter. Adjusted EBITDA was USD 247 million, compared with USD 260 million in the prior-year period. A 2 % global pricing increase and a 1 % currency tailwind more than offset a 2 % volume decline. An additional global TiO 2 price increase effective 1 June 2026 contributed to an approximately 5 % year-to-date price increase in net sales.